Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Leite IDC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-3 z 3
    Tytuł:
    Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.
    Autorzy:
    Jalil EM; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Torres TS; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Luz PM; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Monteiro L; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Moreira RI; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    de Castro CRV; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Leite IDC; Escola Nacional de Saude Publica, Fiocruz, Rio de Janeiro, Brazil.
    Cunha M; Escola Nacional de Saude Publica, Fiocruz, Rio de Janeiro, Brazil.
    de Cássia Elias Estrela R; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Ramos M; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Hoagland B; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Wagner Cardoso S; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Anderson P; Department of Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
    Veloso VG; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Wilson E; San Francisco Department of Public Health, San Francisco, California, USA.
    Grinsztejn B; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Pokaż więcej
    Corporate Authors:
    PrEParadas Study Team; National Institute of Infectious Diseases Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil.
    Źródło:
    Journal of the International AIDS Society [J Int AIDS Soc] 2022 Mar; Vol. 25 (3), pp. e25896.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-HIV Agents*/therapeutic use
    Central Nervous System Stimulants*/therapeutic use
    HIV Infections*/drug therapy
    HIV Infections*/prevention & control
    Pre-Exposure Prophylaxis*
    Transgender Persons*
    Brazil ; Female ; Homosexuality, Male ; Humans ; Male ; Medication Adherence
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study.
    Autorzy:
    Marins LMS; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Torres TS; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Leite IDC; Fundação Oswaldo Cruz, Escola Nacional de Saúde Pública (ENSP/Fiocruz), Rio de Janeiro, Brazil.
    Moreira RI; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Luz PM; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Hoagland B; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Kallas EG; Universidade de São Paulo, Escola de Medicina, São Paulo, Brazil.
    Madruga JV; Centro de Referência e Treinamento em DST/AIDS, São Paulo, Brazil.
    Liu AY; San Francisco Department of Public Health, Bridge HIV, San Francisco, California, United States of America.
    Anderson PL; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, United States of America.
    Grinsztejn B; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Veloso VG; Fundação Oswaldo Cruz, Instituto Nacional de Infectologia Evandro Chagas (INI/Fiocruz), Rio de Janeiro, Brazil.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2019 Aug 20; Vol. 14 (8), pp. e0221281. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use
    HIV Infections/*prevention & control
    Medication Adherence/*statistics & numerical data
    Pre-Exposure Prophylaxis/*statistics & numerical data
    Sexual and Gender Minorities/*statistics & numerical data
    Transgender Persons/*statistics & numerical data
    Adolescent ; Adult ; Anti-HIV Agents ; Brazil ; Dried Blood Spot Testing ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/blood ; Feasibility Studies ; Female ; Humans ; Male ; Pre-Exposure Prophylaxis/methods ; Prospective Studies ; Self Report/statistics & numerical data ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Risk factors for arbovirus infections in a low-income community of Rio de Janeiro, Brazil, 2015-2016.
    Autorzy:
    Rodrigues NCP; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; School of Medical Sciences, Rio de Janeiro State University, Rio de Janeiro, Brazil.
    Daumas RP; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    de Almeida AS; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    Dos Santos RS; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    Koster I; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    Rodrigues PP; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Universidade Federal Fluminense, Niterói, Brazil.
    Gomes MF; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.; Universidade Federal Fluminense, Niterói, Brazil.
    Macedo AF; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    Gerardi A; Georgetown University, Washington, DC, United States of America.
    Leite IDC; National School of Public Health Sergio Arouca, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2018 Jun 07; Vol. 13 (6), pp. e0198357. Date of Electronic Publication: 2018 Jun 07 (Print Publication: 2018).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Epidemics*
    Chikungunya Fever/*epidemiology
    Dengue/*epidemiology
    Adolescent ; Adult ; Brazil/epidemiology ; Cross-Sectional Studies ; Female ; Humans ; Incidence ; Logistic Models ; Male ; Middle Aged ; Population Surveillance ; Socioeconomic Factors ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-3 z 3

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies